Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil clarifies imidacloprid warning labels

The Brazilian environmental agency, the Ibama, has clarified rules with the pesticide industry on the use of warning labels for the neonicotinoid insecticide, imidacloprid, the generic agrochemical industry association, the Aenda, says. The insecticide is among four active ingredients undergoing reassessment over concerns of possible harm to bees ( Agrow No 645, p 16), and warning labels had to be attached from October 17th. The rule applies during the period of the reassessment, while products for seed treatment use only are exempt, but also applies to any products that have gained new approvals. The phrase includes: “This product is toxic to bees, and must neither be applied during the flowering season, nor immediately afterwards; failure to comply constitutes a crime”. The Ibama has sent documents detailing the procedure for the reassessment of imidacloprid to industry associations, and includes 31 files.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG006815

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel